TP53 and neoplasm: However, since the pathway is inactivated by deletion or mutation of p53 or by overexpression of its inhibitors Mdm2 and Mdm4, amongst other mechanisms, p53 reactivation will have to be uniquely tailored to the genetics of a specific tumor type.